Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shujin Jianyao Pills (also known as Shujinjianyao pill or SJJYP) is a traditional Chinese patent medicine formulated as a concentrated honey pill. It is composed of 13 Chinese herbs, including *Cibotii Rhizoma*, *Rosae Laevigatae Fructus*, and *Spatholobi Caulis*. The medicine is traditionally used to tonify the liver and kidney, strengthen muscles and bones, remove wind and dampness, and activate collaterals to relieve pain. It exhibits anti-inflammatory, analgesic, and anti-osteoporotic effects, and is primarily indicated for the treatment of low back pain, sciatica (including liver-kidney deficiency syndrome sciatica from lumbar disc herniation), and sore waist and knees.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shujin Jianyao Pills.